Literature DB >> 19577058

Myocardial viability and cardiac dyssynchrony as strong predictors of perioperative mortality in high-risk patients with ischemic cardiomyopathy having coronary artery bypass surgery.

Michaela Maruskova1, Pavel Gregor, Jozef Bartunek, Jaroslav Tintera, Martin Penicka.   

Abstract

OBJECTIVE: Myocardial viability and left ventricular dyssynchrony are important predictors of long-term outcomes in patients with ischemic left ventricular dysfunction. The objective of this study was to test the hypothesis that assessment of myocardial viability and left ventricular dyssynchrony will predict perioperative mortality in high-risk patients with ischemic left ventricular dysfunction having coronary artery bypass surgery.
METHODS: The study consisted of 79 consecutive patients with ischemic cardiomyopathy (age 65 +/- 9 years; 81% men; ejection fraction 30% +/- 6%) and logistic European system for cardiac operative risk evaluation > 10% having coronary artery bypass surgery. Myocardial viability was assessed by delayed contrast-enhanced magnetic resonance imaging. Left ventricular dyssynchrony was calculated using tissue Doppler from measurements of regional electromechanical coupling times in left ventricular basal segments before coronary artery bypass surgery.
RESULTS: Twenty (25.3%) patients died within 30 days following coronary artery bypass surgery. Survivors (n = 59) showed a larger extent of viable myocardium (6.9 +/- 3.6 viable segments vs 3.4 +/- 3.3 viable segments, P < .001) and smaller left ventricular dyssynchrony (75 +/- 5 ms vs 179 +/- 83 ms, P < .001) than nonsurvivors. The presence of significant dyssynchrony (>or=105 ms) and absence of myocardial viability (<5 viable segments) independently predicted 30-day mortality with hazard ratio 3.26, 95% confidence interval 1.61 to 8.33 (P < .01) and hazard ratio 1.72, 95% confidence interval 1.59 to 1.89 (P < .01), respectively. All but 2 patients (94.1%) with viable myocardium and without left ventricular dyssynchrony survived coronary artery bypass surgery as compared with only 12 (52.2%) patients with nonviable myocardium and severe dyssynchrony (P < .001).
CONCLUSIONS: In high-risk patients with ischemic left ventricular dysfunction having coronary artery bypass surgery, both myocardial viability and left ventricular dyssynchrony are important predictors of perioperative outcome. Assessment of myocardial viability and left ventricular dyssynchrony should be a routine part of the preoperative evaluation of these patients.

Entities:  

Mesh:

Year:  2009        PMID: 19577058     DOI: 10.1016/j.jtcvs.2008.11.040

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  eComment. Cardiac resynchronization therapy in cardiac surgery.

Authors:  Jamil Hajj-Chahine; Christophe Jayle; Jacques Tomasi; Pierre Corbi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-11

2.  Left ventricular dyssynchrony assessment by phase analysis from gated PET-FDG scans.

Authors:  Aju P Pazhenkottil; Ronny R Buechel; Rene Nkoulou; Jelena-Rima Ghadri; Bernhard A Herzog; Lars Husmann; Mathias Wolfrum; Silke M Küest; Michael Fiechter; Oliver Gaemperli; Philipp A Kaufmann
Journal:  J Nucl Cardiol       Date:  2011-06-14       Impact factor: 5.952

3.  Left ventricular dyssynchrony assessed by gated SPECT phase analysis is an independent predictor of death in patients with advanced coronary artery disease and reduced left ventricular function not undergoing cardiac resynchronization therapy.

Authors:  Christopher Uebleis; Stefan Hellweger; Rüdiger Paul Laubender; Alexander Becker; Hae-Young Sohn; Sebastian Lehner; Alexander Haug; Peter Bartenstein; Paul Cumming; Serge D Van Kriekinge; Piotr J Slomka; Marcus Hacker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-07-03       Impact factor: 9.236

4.  Myocardial Regional Interstitial Fibrosis is Associated With Left Intra-Ventricular Dyssynchrony in Patients With Heart Failure: A Cardiovascular Magnetic Resonance Study.

Authors:  Lian-Yu Lin; Cho-Kai Wu; Jyh-Ming Jimmy Juang; Yi-Chih Wang; Mao-Yuan Marine Su; Ling-Ping Lai; Juey-Jen Hwang; Fu-Tien Chiang; Wen-Yih Issac Tseng; Jiunn-Lee Lin
Journal:  Sci Rep       Date:  2016-02-05       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.